Literature DB >> 12573571

Hepatitis C virus NS2 protein inhibits gene expression from different cellular and viral promoters in hepatic and nonhepatic cell lines.

Franz Ludwig Dumoulin1, Annette von dem Bussche, Jisu Li, Leila Khamzina, Jack R Wands, Tilman Sauerbruch, Ulrich Spengler.   

Abstract

The mechanisms leading to viral persistence and hepatocarcinogenesis in hepatitis C virus (HCV) infection are not fully understood. Recently, evidence has been accumulated that HCV viral proteins might interfere with gene expression of host cells. Here, we demonstrate that the amino-terminal portion of HCV NS2 protein inhibits the expression of reporter genes driven by different promoters or enhancer elements and also inhibits hepatitis B virus (HBV) gene expression and HBV DNA replication. The inhibitory effect of HCV NS2 on liver and non-liver-specific promoters and enhancer elements might be relevant for the pathogenesis of chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12573571     DOI: 10.1006/viro.2002.1701

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.

Authors:  E Rodríguez-Iñigo; J Bartolomé; N Ortiz-Movilla; C Platero; J M López-Alcorocho; M Pardo; I Castillo; V Carreño
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

Authors:  Kyoungsub Song; Chang Han; Srikanta Dash; Luis A Balart; Tong Wu
Journal:  World J Hepatol       Date:  2015-03-27

Review 3.  Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.

Authors:  Michael J Bouchard; Sonia Navas-Martin
Journal:  Cancer Lett       Date:  2010-12-18       Impact factor: 8.679

Review 4.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

5.  Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.

Authors:  Nathalie Franck; Jacques Le Seyec; Christiane Guguen-Guillouzo; Lars Erdtmann
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication.

Authors:  Annette von dem Bussche; Raiki Machida; Ke Li; Gideon Loevinsohn; Amrin Khander; Jianguo Wang; Takaji Wakita; Jack R Wands; Jisu Li
Journal:  J Hepatol       Date:  2010-07-24       Impact factor: 25.083

Review 7.  Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Authors:  Jason T Blackard; Kenneth E Sherman
Journal:  Rev Med Virol       Date:  2018-05-15       Impact factor: 6.989

8.  Determinants of the hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus.

Authors:  Thomas G Dentzer; Ivo C Lorenz; Matthew J Evans; Charles M Rice
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

Review 9.  Hepatitis C virus proteins.

Authors:  Jean Dubuisson
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

Review 10.  Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection.

Authors:  Peiman Habibollahi; Saeid Safari; Nasser E Daryani; Seyed M Alavian
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.